Daniel Carlat, MD

EXPERT Q&A

20 Years of The Carlat Report

January 1, 2023

Daniel Carlat, MD.

Medical Director of Inpatient Psychiatry/Chairman of Psychiatry at Melrose Wakefield Healthcare. Publisher, Carlat Publishing.

Dr. Carlat has no financial relationships with companies related to this material.

Twenty years ago, Danny Carlat walked away from industry-funded education and started The Carlat Report. Here he looks back on pivotal moments that have changed the field and shares his perspective on the controversies of today.

Medication Fact Book for Psychiatric Practice, Sixth Edition (2022)

PDF/eBook Access with 12 CME Post-Test

April 1, 2022

Talia Puzantian, PharmD, BCPP and Daniel Carlat, MD

Dr. Puzantian and Dr. Carlat have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

This page has links and instructions for taking the 12 CME post-test for the Medication Fact Book for Psychiatric Practice, Sixth Edition (2022) and download links PDF/eBook access.

Medication Fact Book for Psychiatric Practice, Sixth Edition (2022)

PDF/eBook Access with 12 CME Post-Test

April 1, 2022

Talia Puzantian, PharmD, BCPP and Daniel Carlat, MD

Dr. Puzantian and Dr. Carlat have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

This page has links and instructions for taking the 12 CME post-test for the Medication Fact Book for Psychiatric Practice, Sixth Edition (2022) and download links PDF/eBook access.

Medication Fact Book for Psychiatric Practice, Sixth Edition (2022)

PDF/eBook Access with 12 CME Post-Test

April 1, 2022

Talia Puzantian, PharmD, BCPP and Daniel Carlat, MD

Dr. Puzantian and Dr. Carlat have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

This page has links and instructions for taking the 12 CME post-test for the Medication Fact Book for Psychiatric Practice, Sixth Edition (2022) and download links PDF/eBook access.

Prescribing Psychotropics: From Drug Interactions to Pharmacogenetics (2022)

PDF/eBook with CME Post-Test Access

January 1, 2022

Chris Aiken, MD, Joshua Feder, MD, and Daniel Carlat, MD

Dr. Aiken, Dr. Feder, and Dr. Carlat have no relevant financial relationship(s) with ineligible companies to disclose.

This page has links and instructions for taking the 10 CME post-test for Prescribing Psychotropics (2022) and downloading your PDF and eBook copies.

Prescribing Psychotropics: From Drug Interactions to Pharmacogenetics (2022)

PDF/eBook Access and CME Post-Test

January 1, 2022

Chris Aiken, MD, Joshua Feder, MD, and Daniel Carlat, MD

Dr. Aiken, Dr. Feder, and Dr. Carlat have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity. have no relevant financial relationship(s) with ineligible companies to disclose.

This page has links and instructions for taking the 10 CME post-test for Prescribing Psychotropics (2022) and downloading your PDF and eBook copies.

Medications to Rapidly Treat Psychotic Agitation

September 13, 2021

Victoria Hendrick, MD. and Daniel Carlat, MD

Victoria Hendrick, MD. Editor in Chief, The Carlat Hospital Psychiatry Report. Chief, Inpatient Psychiatry, Olive View UCLA Medical Center.

Daniel Carlat, MD. Publisher, The Carlat Hospital Psychiatry Report.

Dr. Hendrick and Dr. Carlat have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

How do you choose medications to calm an acutely psychotic and agitated patient? We'll tell you which ones are the safest and most effective.

IM Olanzapine Plus Benzodiazepines: Safe or Unsafe?

September 13, 2021

Victoria Hendrick, MD. and Daniel Carlat, MD

Victoria Hendrick, MD. Editor in Chief, The Carlat Hospital Psychiatry Report. Chief, Inpatient Psychiatry, Olive View UCLA Medical Center.

Daniel Carlat, MD. Publisher, The Carlat Hospital Psychiatry Report.

Dr. Hendrick and Dr. Carlat have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

If you have ever tried to electronically prescribe IM olanzapine with an IM/IV/subcutaneous benzodiazepine, you have probably received an interaction alert warning about the potential for excessive sedation and cardiorespiratory depression. Is this warning justified? Let’s look at the data.

Intranasal Esketamine: New Hope for Suicidal Patients?

April 12, 2021

Victoria Hendrick, MD. and Daniel Carlat, MD

Victoria Hendrick, MD.

Editor in Chief, The Carlat Hospital Psychiatry Report. Chief, Inpatient Psychiatry, Olive View UCLA Medical Center.

Daniel Carlat, MD. Publisher, The Carlat Hospital Psychiatry Report. Dr. Hendrick and Dr. Carlat have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Imagine a drug that resolves depression within hours in people at imminent risk of suicide. Esketamine may be such a drug — but is it a miracle cure? Here we look at the data and discuss the pros and cons of this new treatment.

Non-Addictive, Pharmacological Options for Sleep

August 23, 2018

Daniel Carlat, MD

Daniel Carlat, MD Publisher, The Carlat Addiction Treatment Report Dr. Carlat has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

In this month’s interview with Dr. Eric Hermes, we learned about his approach to treating insomnia in patients with substance use disorders, with a focus on cognitive behavioral therapy. In this article, we’ll look at some non-addictive pharmacological options.